Novartis’s $9.7 Billion Purchase Includes Novel PCSK9 Inhibitor
Novartis’s $9.7 Billion Purchase Includes Novel PCSK9 Inhibitor
The pharmaceutical firm is buying The Medicines Company, which recently devoted its efforts into developing the cholesterol-lowering medication.
Novartis’s $9.7 Billion Purchase Includes Novel PCSK9 Inhibitor
Novartis’s $9.7 Billion Purchase Includes Novel PCSK9 Inhibitor

The pharmaceutical firm is buying The Medicines Company, which recently devoted its efforts into developing the cholesterol-lowering medication.

The pharmaceutical firm is buying The Medicines Company, which recently devoted its efforts into developing the cholesterol-lowering medication.

cholesterol
Study of Ugandan Genomes Yields Novel Variants, Health Links
Study of Ugandan Genomes Yields Novel Variants, Health Links
Shawna Williams | Oct 31, 2019
The authors say their results demonstrate the global benefits of studying African genetics.
Immune “Webs” May Aid the Formation of Gallstones
Immune “Webs” May Aid the Formation of Gallstones
Emma Yasinski | Aug 22, 2019
Researchers find evidence of neutrophil extracellular traps (NETs), sticky clumps of DNA and protein extruded by neutrophils, holding gallstones together.
<em>The Scientist</em>&rsquo;s Most Stunning Infographics of 2018<em>The Scientist</em>&rsquo;s Most Stunning Infographics of 2018
The Scientist’s Most Stunning Infographics of 2018
Jef Akst | Dec 21, 2018
From cellular self-digestion to the effects of exercise on the brain, our features editor picks her favorite art custom-made for the magazine.
Limited Meal Times Prevent Obesity in Mice Prone to Gaining Weight
Limited Meal Times Prevent Obesity in Mice Prone to Gaining Weight
Abby Olena | Aug 30, 2018
Even in mice with a busted circadian clock and an unhealthy diet, carefully timed feeding overcomes the rodents’ predispositions for metabolic diseases.
Gene Editing Reduces Monkeys&rsquo; Cholesterol
Gene Editing Reduces Monkeys’ Cholesterol
Ashley Yeager | Jul 10, 2018
The results could lead to a treatment to lower cholesterol in patients with hypercholesterolemia.
Alfred Alberts, Lovastatin Discoverer, Dies
Alfred Alberts, Lovastatin Discoverer, Dies
Kerry Grens | Jul 5, 2018
The Merck biochemist found the compound that led to a popular cholesterol-lowering drug.
Infographic: Piecing the Cholesterol Puzzle
Infographic: Piecing the Cholesterol Puzzle
Diana Kwon | May 1, 2018
How a rare disease led to an understanding of the basics of cholesterol regulation.
PCSK9 Drug Reduces Heart Disease Risk
PCSK9 Drug Reduces Heart Disease Risk
Diana Kwon | Mar 21, 2017
A cholesterol-lowering drug significantly cut the risk of heart attack and stroke in a recent study. But is it worth the steep cost?
Inaccurate Cholesterol Tests from Theranos
Inaccurate Cholesterol Tests from Theranos
Jef Akst | Mar 29, 2016
The company’s finger-prick tests yield cholesterol levels notably lower than results of traditional blood draw tests from two other large companies, according to a study.